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F. Javier Blázquez Ruiz, Pamplona (Navarre) / Spain* 
 
Nanotechnologies and Health: Juridical and Philosophical Implications 
 
Abstract: Although their applications have not yet extended widely due to their incipient state, nano-
technologies and nano-medicines may be presumed to be at the origin of the next great technological 
revolution, foreseeably contributing to a new stage with respect to evolutions in mankind’s progress. 
Their possibilities are truly immense in enormously varied spheres, but the risks and uncertainties 
they engender are enormous too. Because access and use of the unceasingly increasing mega-quantity 
of information they generate will place further strain on the protection of personal life, privacy, the 
exercise of freedom, as well as the safeguarding of other fundamental principles and rights.  
Keywords:  Nanotechnology,  nano-particles,  diagnostics,  health,  risks,  respect  and  protection  of 
rights, responsibility 
 
I. Beyond a doubt, in the past decade the rise in nanotechnologies has been incessant. The 
possibilities  that  emerge  from  the  convergence  of  the  various  disciplines  involved  are 
obviously enormous.  But the challenges raised in various fields are daunting as well. 
We consequently see the emergence of inevitable questions, such as: what might be the 
effects of nanoparticles on states of health and the environment? What grade of toxicity and 
what level of health risk might nanomaterials generate? 
On the other hand, what effects might these nanoproducts have if they are introduced into 
the food chain? And, due to their microsize, will these new ultra-fine particles be able to cross 
cellular membranes like the skin, e.g., ordinarily protecting the organism against external 
aggressions?
1 
Also, from the labor aspect, unavoidable questions arise too, like those involving ways of 
detecting these nanoparticles and how to protect workers from them. With respect to the 
economic dimension, the repercussions will also be quite varied. For example, the downsizing 
of products developed will considerably lower manufacturing costs, as well as distribution 
and sale estimates. But that process will have consequences in the developing countries that 
are the main suppliers of minerals and metals as raw materials. 
From another perspective, both the access and use of an enormous mass of information – 
that is constantly increasing – via microprocessors, will be able to place at risk the respect and 
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protection of fundamental rights relating to private life, in reference to aspects of intimacy or 
privacy, unless that information mass be subjected to a certain control. 
Therefore  it  is  hardly  surprising  that  from  2004  on  the  European  Commission  has 
repeatedly called for a “frank (approach) to the potential risks to public health, security, the 
environment or consumers in general, generating the data necessary for evaluating those risks, 
and integrating the risk evaluation into every stage of the lifecycle of products produced by 
nanotechnologies”
2.  The  same  might  be  said  of  UNESCO  and  its  manifest  interest  in 
encouraging a process of prospective reflection on the course of recent developments in new 
technologies and, particularly, in nanotechnologies
3. 
Along these lines, the European Commission has promoted ‘a public consultation’ (2008) 
on the project of a code of conduct for responsible investigation in the domain of nanociences 
and nanotechnologies. This Code will be founded on respect for the Charter of fundamental 
human rights of the European Union, on the European Convention on the Rights of Man, the 
European Convention on Human Rights and Biomedicine signed in Oviedo, and the Aarhus 
Convention  concerning  access  to  information,  public  participation  and  respect  for  the 
environment. 
The expected form will involve a recommendation from the European Commission and 
will invite Member States, industry and universities, as well as other economic and social 
agents,  to  follow  determined  criteria,  in  particular  three  basic  principles:  “precaution, 
inclusiveness and integrity”
4. 
Basing ourselves on these references, It is easy to see the obvious need and desirability of 
addressing  the  applications  and  implications  of  nanotechnologies  from  a  bioethical 
perspective. There is really a lot at stake. And the balanced and interdisciplinary reflection of 
the human, social and juridical sciences cannot remain on the margins or insensible to the 
challenges coming from these new technologies.  
Only in  this  way will it  be possible to  avoid,  on the one hand, the utopian dreams, 
optimistic in character but unreal and negligent, that some propose, with unforseeable long 
term effects
5. And, too, on the other hand, we will be armed with data, analysis and rational 
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arguments against the possible apocalyptical nightmare sometimes accompanying speech and 
debate on the future of nanotechnologies. 
And in fact the challenges of nanotechnologies do not just concern the fields of health or 
the  environment.  They  are  also  challenges  impregnated  with  a  cultural,  ethical  and 
anthropological character – broadly speaking. Additionally, as Weill moreover warns, they 
appear as strategic in the economic, and even military, spheres
6. Nor are they in any way alien 
to political, juridical and social dimensions, taking into account the international dimension of 
the markets – i.e., their global character
7. 
Once again, as happened with the Human Genome Project, at the request of Dr. J. 
Watson, simultaneous reflection during the investigation and application process (but, not a 
posteriori as had occurred until then with other scient ific projects) on the various ethical, 
juridical and social implications (ELSI), becomes unavoidable
8. And inaugurating access to 
an open domain, not restricted to the most interested agents, cannot be postponed. 
This is also the proposal that is most read ily agreed to, as J.P. Dupuy affirms, openly 
defending a process of reflection in real time on the changes and transformations originating 
in scientific and technical exchange. Because it makes no sense to hope to know the results 
and react later. 
On the contrary, this is to be done precisely in order to advance at the same speed as its 
development and, if possible, “anticipate its projection by means of impact studies and a 
permanent monitoring, no less interdisciplinary than that characterizing nanociences
9.  
Only in this way will we realize the need to integrate the treatment of nanomaterials into 
the laws of health and environmental risk, for it adds up to an unavoidable exigency, as we 
shall see now. 
 
II. If we now approach nanotechnologies more concretely from a juridical point of view, the 
first thing that should be noted is that present-day regulations seem inadequate because they 
are insufficient. Various organizations work to regulate and provide answers to the questions 
emerging in the development and application of nanotechnologies.  
This is the case e.g. for European programmes like Nanosafe, Nanoderm or Shape Risk. 
In this respect, AFNOR (French Association for Standardization), CEN (European Committee 
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for Standardization), as well as the ISO (for International Organization for Standardization) 
try to elaborate standards concerning nanotechnology and nanopartícles. 
In fact, a high degree of uncertainty really does exist on the derivative risks related to the 
use of nanotechnologies. This uncertainty, sometimes generating fear, leads us to think that 
we are faced with conditions and circumstances that justify a thorough application of the 
precautionary principle.  
In  this  way  we  will  be  able  to  closely  follow  the  development  of  nanotechnologies, 
classifying and orienting them, simultaneously specifying both their positive and negative 
aspects. 
Because  today,  obvious  lacunae  exist  with  respect  to  the  treatment  of  potential 
nanotechnological risks. These lacunae are due to the relative newness of these nanofabricated 
materials;  this  has  brought  about  a  certain  temporary  unbalance  between  the  juridical 
understanding of the risks and, on the other hand, the latters’ scientific evaluation.  
Echoing  this  concern,  the  European  Parliament  has  proposed  incorporating  specific 
provisions referring to nanoparticles – in the Reach regulation, with a view to ensuring an 
“adequate evaluation of the latters’ security”
10. 
In  this  respect,  it  helps  to  realize  that  the  production  of  standards  regarding  laws 
governing health and environmental risks is to a good degree “sophisticated” – to such a point 
that we can say with Hervé-Fournereau that “its family tree resembles an ancient labyrinth”
11. 
In  this  sense,  since  2004,  numerous  European  and  internationally-based  information 
sources,  recognize  the  potentiality  for  health  and  environmental  risks,  while  insisting  on 
urgently intensifying investigations. These studies have repeatedly pointed out the absence of 
relevant  scientific  data,  such  as:  census  and  characterization  of  materials,  sectors  of  the 
population exposed to risk, deficits in methodologies as well as standardized and validated 
measurement  tools,  etc.
12  The  few  published  studies  that  examine  the  interactions  of 
nanoparticles at cellular levels, invite caution. 
In 2004 – in fact – the European Commission organized a workshop on the risks of 
nanotechnologies.  They  considered  five  possible  scenarios  concerning  health  and 
environmental impacts. Concretely, they consist in: laissez-faire, establishing a moratorium, 
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resorting to voluntary approaches, the adoption of specifically targeted legislation and the 
progressive adaptation of existing legislation. 
Among such possibilities, the Commission clearly showed its preference for resorting “to 
existing  regulations,  as  much  as  possible”.  And  it  voiced  its  frontal  opposition  to  the 
possibility of applying a clear and explicit moratorium, considering that option “dangerously 
counter-productive
13. 
As we indicated before, in this respect, the proposal to apply the juridical precautio nary 
principle as a regulating criterion seems more than reasonable – in terms of responsibility. In 
fact, the precautionary principle included in the European Union Treaty of Maastrich was 
later ratified in the Treaty of Amsterdam, and later in the Treaty of Nice.  
These  texts,  amounting  to  pillars  of  EU  jurisprudence  with  respect  to  environmental 
protection, subsequently resulted in jurisprudence – both European and national – extending 
its reach “to health risks”. 
Nevertheless  the  standards  existing  –  until  the  moment  when  responsibility  and 
reparation regarding health and environmental damage be regulated - are obviously paltry 
and,  hence,  insufficient.  Consequently,  for  technical  reasons,  it  is  difficult  to  impute 
responsibilities in cases of damage
14. 
 
III. Undoubtedly, once further information is available on the risks of nanoparticles, it will be 
that much easier for both health professionals and patients to make decisions. That decision-
making process, accepting the risk-benefit tradeoff at the time of confronting a diagnosis or a 
therapeutic treatment in which nanoparticles are included, will be carried out in the same way 
“as that currently practiced with all implemented diagnostic and therapeutic procedures that 
have the scientific community’s acceptance
15. 
Nevertheless, it should be pointed out that there is a glaring difference, not only as to the 
difference but also the disproportion, existing between nanotechnological investment and 
budgets assigned  for analyzing security and health risks. Hence i t will not be easy to 
simultaneously realize a precise determination of the benefits and risks of nanomaterials. Both 
of which, it should be pointed out, are potential. 
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On the other hand, studies and directed tests  to minimize the risks  of nanomaterials 
throughout their life cycle will require the cooperation of multidisciplinary investigations, 
that, still, in certain cases will make use of size scales superior to those of nanometry
16.  
Doubtlessly protecting people exposed to the potential risks of nanoma terials requires 
information adapted to such risks in accordance with laws on access to information and the 
principle of transparency. This demand for public information is encountered regularly in all 
recent texts on environmental and health law. 
In  this  sense  the  European  Commission  recognizes  that  it  is  “imperative  that  the 
development  of  nanotechnologies  be  open,  traceable  and  controlable,  in  conformity  with 
democratic principles”. But it additionally insists on the need to open channels of information 
to society, while it invites Member States “to adopt an overture, a frank rapprochement and a 
dynamic dialogue with respect to R&D policies on nanotechnology, with a view “to gaining 
the interest and confidence of the greater public”
17.  
In  this  respect,  we  should  bear  in  mind  that  an  increasingly  visible  and  established 
tendency  exists,  consisting  in  allocating  and  shifting  a  part  of  the  financing  of  basic 
theoretical  investigation  towards  applied  investigation,  to  the  detriment  of  a  more 
fundamentals based education. As Schumer proposes, it would be advisable to include ethical 
contents and proposals/scenarios in scientists’ academic formation, so as to avoid falling into 
the practice of investigations considered to be “ethically neutral”
18.  
A practice that can in some sense erode and devalue – in this case by omission – exercise 
of the responsibility principle, which, as is well known, constitues the fundamental principle 
of the normative order in both ethical reflection and law.  
And consequently, as we indicated earlier, this may affect access to sensitive, valuable 
information, related to personal aspects, meaning of a private character and intimate, which 
may eventually lead to a possible infringement on fundamental rights. 
So,  after  all,  it  is  not  surprising  that  a  good  part  of  public  opinion  voices  an  ever 
increasing  demand  for  “the  establishment  of  guarantees  safeguarding  citizens  against 
technological invasions of their privacy”
19. 
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